Supplementary Material for: Infectious Disease Screening Prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation
Kozera E.K., Frew J.W., E. McMeniman, Martina L. Porter(Beth Israel Deaconess Medical Center), Ring H.C., Paek S.Y., Oon H.H., K. Glasenhardt, Chandran N.S., Dillon Mintoff(University of Malta)
Cited by 0
Related Papers
Psoriasis: Keratinocytes or Immune Cells – Which Is the Trigger?
|Dermatology|2018|227
Psoriasis and Microbiota: A Systematic Review
|Diseases|2018|135
The Genomic Architecture of Hidradenitis Suppurativa—A Systematic Review
|Frontiers in Genetics|2022|117
EULAR study group on ‘MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders
|Annals of the Rheumatic Diseases|2023|79
Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects
|International Journal of Dermatology|2021|57